← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Virovax Llc
Lawrence, KS
$9,273,907
Total funding
1
Grants
Funding over time
peak $4.3M · FY2018–22$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,273,907 · 1
By mechanism
N01$9,273,907 · 1
Investigators at Virovax Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus$3,635,428
N01 · FY2020 · AI
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus$1,983,970
N01 · FY2022 · AI
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus$1,513,468
N01 · FY2018 · AI
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus$1,216,047
N01 · FY2019 · AI
ADJUVANT DEVELOPMENT PROGRAM - COVID-19 Supplement$649,995
N01 · FY2020 · AI
Develop a candidate subunit vaccine for Powassan Virus and West Nile virus adjuvanted with Alhydroxiquim-II$274,999
N01 · FY2022 · AI